相关实验视频

Updated: Sep 18, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

一个针对线粒体的纳米酶平台,用于通过铁和细胞灭调节的多途径瘤治疗

Chenguang Liu^1,2, Lingxiao Guo¹, Yuying Cheng¹

¹College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, P. R. China.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

|June 25, 2025

概括

这项研究介绍了一种新的纳米平台,可以提供铜和铁离子,通过铁和致癌诱导协同性癌细胞死亡,显示出显著的抗瘤作用.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
癌症治疗方法癌症治疗方法

背景情况:

过渡金属纳米酶通过化学动力学疗法和ferroptosis/cuproptosis诱导提供了有希望的癌症治疗策略.
同时输送铜和铁离子,以及线粒体向铜在亡中的作用,需要进一步调查.

研究的目的:

开发一个双功能纳米异质连接平台,用于在癌症治疗中协同诱导铁和杯.
调查针对线粒体的铜和铁离子输送的有效性,以提高抗瘤活性.

主要方法:

制造一个双功能纳米异质连接平台 (MIL-Cu1.8S-TPP/FA),集成铁和铜组件.
使用针对线粒体的Cu1.8S纳米点和基于铁的MIL-88B金属有机框架.
密度函数理论 (DFT) 分析以确认增强的活性氧物种 (ROS) 催化活性.

主要成果:

纳米异质连接平台通过破坏线粒体铁硫蛋白质,有效诱导了cuproptosis.
观察到增强的ROS催化活性和改善的H2O2吸附.
该平台调节了关键的铁亡和亡标记物 (GPX4,GSH,FDX-1,HSP70),证明了显著的体外和体外抗瘤疗效.

结论:

开发的纳米平台协同结合了光热效应与多途径细胞死亡机制,以有效治疗癌症.
铜和铁离子的同步输送,加上线粒体向,是多模式癌症治疗的有希望的策略.

关键词:

这就是cuproptosis.铁性化 (ferroptosis) 是一种细胞内血液静止细胞内血液静止基于金属的纳米复合材料.纳米酶纳米酶是一种纳米酶.

更多相关视频

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Peroxisomes and Mitochondria

Peroxisomes and Mitochondria

Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...